PRAH - PRA Health Sciences Inc
Close
165.21
-2.800 -1.695%
Share volume: 0
Last Updated: Wed 30 Jun 2021 10:00:01 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$168.01
-2.80
-1.67%
Summary score
22%
Profitability
25%
Dept financing
20%
Liquidity
25%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2017 - 2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
4.03%
Return on assets
2.3%
Return on sales
10.79%
Return on invested capital
2.9%
Total debt ratio
68.57%
Debt ratio change over timeo
62.5%
Current Ratio
1%
Quick Ratio
0.99%
Cash Position Ratio
0.22%
Short-term ratios 2020 - 2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.8%
Return on assets
1.88%
Return on sales
8.99%
Return on invested capital
3.47%
Total debt ratio
65.59%
Debt ratio change over timeo
-4.53%
Current Ratio
1.12%
Quick Ratio
1.12%
Cash Position Ratio
0.36%
Last quarter ratios 2021
The data are presented for the financials results of the last quarter.
Return on equity
3.66%
Return on assets
1.94%
Return on sales
8.9%
Return on invested capital
4.17%
Total debt ratio
63.66%
Debt ratio change over time
14.25%
Current Ratio
1.21%
Quick Ratio
1.21%
Cash Position Ratio
0.52%
Performance ratios (change over 4 years) 2017 - 2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
290.9%
Return on assets
103.88%
Return on sales
827.81%
Return on invested capital
139.96%
Total debt ratio
6249.75%
Debt ratio change over time
62.5%
Current Ratio
82.61%
Quick Ratio
88.85%
Cash Position Ratio
12.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PRAH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 4.03% | -6.02% | 13.65% | 6.98% |
| Return on assets | 2.3% | 3.39% | 3.61% | 5.41% |
| Return on sales | 10.79% | 30.6% | 40.46% | 35.45% |
| Return on invested capital | 2.9% | 4.76% | 7.3% | 15.54% |
| Profitability | 29% | 42% | 78% | 85% |
| Total debt ratio | 68.57% | 100.95% | 78.51% | 29.4% |
| Debt ratio change over time | 62.5% | 258.46% | 7.2% | 1.53% |
| Dept financing | 23% | 50% | 20% | 7% |
| Current Ratio | 1.12% | 0.87% | 1.98% | 3.19% |
| Quick Ratio | 1.12% | 0.74% | 1.63% | 2.54% |
| Cash Position Ratio | 0.36% | 0.29% | 0.88% | 1.14% |
| Liquididy | 19% | 31% | 57% | 75% |
| Short-term ratios | PRAH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 3.8% | 8.95% | 17.54% | 9.49% |
| Return on assets | 1.88% | 2.19% | 3.45% | 5.63% |
| Return on sales | 8.99% | 25.57% | 35.22% | 39.9% |
| Return on invested capital | 3.47% | 1.34% | 5.79% | 24.68% |
| Profitability | 23% | 40% | 68% | 89% |
| Total debt ratio | 65.59% | 90.54% | 84.19% | 35.66% |
| Debt ratio change over time | -4.53% | 1037.1% | 13.92% | 1.92% |
| Dept financing | 18% | 50% | 24% | 10% |
| Current Ratio | 1.12% | 0.87% | 1.98% | 3.19% |
| Quick Ratio | 1.12% | 0.74% | 1.63% | 2.54% |
| Cash Position Ratio | 0.36% | 0.29% | 0.88% | 1.14% |
| Liquididy | 28% | 20% | 51% | 75% |